Aslan Pharmaceuticals | 6-K:外国发行人报告(业绩相关)
Aslan Pharmaceuticals | 6-K:外国发行人报告(业绩相关)
Aslan Pharmaceuticals | 6-K:外国发行人报告
Aslan Pharmaceuticals | 6-K:外国发行人报告
Aslan Pharmaceuticals | 6-K:外国发行人报告
Aslan Pharmaceuticals | 424B5:募资说明书
Aslan Pharmaceuticals | 6-K:外国发行人报告
Aslan Pharmaceuticals | S-8:员工福利计划证券登记
Aslan Pharmaceuticals | 20-F:年度报告/过渡报告/注册声明
Aslan Pharmaceuticals | 6-K:外国发行人报告(业绩相关)
Aslan Pharmaceuticals | EFFECT:其他
Aslan Pharmaceuticals | D:发行公告
Aslan Pharmaceuticals | CORRESP:信函
Aslan Pharmaceuticals | UPLOAD:其他
Aslan Pharmaceuticals | F-3:交易注册声明
Aslan Pharmaceuticals | SC 13G:超过5%持股股东披露文件-Mitchell P. Kopin(4.4%),Daniel B. Asher(4.4%)等
Aslan Pharmaceuticals | SC 13G:超过5%持股股东披露文件-Lind Global Fund II LP(5.7%),Lind Global Partners II LLC(5.7%)等
Aslan Pharmaceuticals | 424B5:募资说明书
Aslan Pharmaceuticals | 6-K:外国发行人报告(业绩相关)
Aslan Pharmaceuticals | 6-K:外国发行人报告
暂无数据